Stay up to date on the orthopedic market’s 3Q performance in 2025 as we update this post with company sales data and industry developments.
The Numbers
The company grew in the high single digits on a reported basis for the third quarter of 2025 and saw improved U.S. performance.
Excluding its divested spinal implant business, Stryker’s orthopedic sales grew in the double digits for the third quarter of 2025.
Orthoflash®
The UniSpace lumbar device was designed to be compatible with CGBio’s next-generation NOVOSIS Putty bone graft substitute.
November 7, 2025
,
The system is designed to provide truly patient-specific custom solutions for revisions, deformities, arthritic conditions, and trauma-related foot and ankle injuries.
November 7, 2025
,
The synthetic, absorbable gel is for use as an adjunct in lumbar spine surgery for the reduction of leg pain and neurological symptoms.
November 5, 2025
,
The launch further expands Xtant’s biologics product portfolio to include a surgical wound closure application.
November 5, 2025
,
SnkeXR was designed specifically to aid the medical technology industry with integration and adoption of AR technologies into healthcare workflows.
November 3, 2025
,
Competitive Landscape
ORTHOWORLD Experts talk you through market forecasts, company sales and key trends.
Industry Voices
